For the quarter ending 2025-12-31, MCHPP had $13,900K increase in cash & cash equivalents over the period. $318,900K in free cash flow.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Net income | 62,700 | 41,700 | -18,600 | -154,600 |
| Depreciation and amortization | 171,800 | 172,700 | 171,100 | 187,000 |
| Deferred income taxes | -15,600 | 5,300 | -3,000 | -17,500 |
| Share-based compensation expense related to equity incentive plans | 72,600 | 61,600 | 52,900 | 40,700 |
| Loss on settlement of debt | 0 | - | - | -1,400 |
| Amortization of debt discount | 12,900 | 5,300 | 1,400 | 13,200 |
| Amortization of debt issuance costs | 1,300 | 1,300 | 1,400 | 1,700 |
| Impairment of intangible assets | 0 | 300 | 2,200 | 0 |
| Other | -12,500 | 4,800 | -600 | -17,500 |
| (increase) decrease in accounts receivable | -15,000 | -19,900 | 75,800 | -167,500 |
| Decrease (increase) in inventories | -39,000 | -76,000 | -125,000 | -66,700 |
| Decrease in accounts payable and accrued liabilities | -1,400 | -53,600 | 27,600 | -109,000 |
| Change in other assets and liabilities | 16,300 | 72,400 | 3,400 | -34,600 |
| Change in income tax payable | 11,900 | -174,800 | -4,600 | -8,300 |
| Net cash provided by operating activities | 341,400 | 88,100 | 275,600 | 205,900 |
| Other investing | 0 | -1,300 | - | 0 |
| Proceeds from capital-related government incentives | 0 | 300 | 4,800 | 300 |
| Investments in other assets | 22,000 | 27,100 | 23,800 | 42,100 |
| Capital expenditures | 22,500 | 36,500 | 17,900 | 14,200 |
| Net cash used in investing activities | -44,500 | -62,000 | -36,900 | -56,000 |
| Proceeds from borrowings on revolving credit facility | - | - | - | 68,000 |
| Proceeds from borrowings on revolving credit facility | - | - | - | 68,000 |
| Proceeds from borrowings on 2025 term loan facility | - | - | - | 0 |
| Repayments of 2025 term loan facility | 0 | - | - | 0 |
| Proceeds from issuance of commercial paper | 2,799,100 | 1,588,400 | 0 | 3,370,400 |
| Repayments of commercial paper | 2,810,400 | 476,000 | 174,100 | 4,483,000 |
| Proceeds from issuance of senior notes | 0 | - | - | 0 |
| Repayment of senior notes | 0 | 1,200,000 | - | 0 |
| Proceeds from issuance of convertible debt | 0 | 0 | 0 | 0 |
| Payments on settlement of convertible debt | 0 | - | - | 3,700 |
| Issuance of series a preferred stock | - | - | - | 1,449,500 |
| Deferred financing costs | 0 | 0 | 0 | 1,700 |
| Purchase of capped call options | 0 | 0 | 0 | 55,100 |
| Proceeds from sale of common stock | 12,200 | 17,900 | 12,400 | 20,000 |
| Tax payments related to shares withheld for vested rsus | 9,600 | 11,600 | 8,400 | 12,600 |
| Repurchase of common stock | 0 | 0 | 0 | 0 |
| Payment of cash dividends on series a preferred stock | 27,800 | 27,800 | 25,100 | - |
| Payment of cash dividends | - | - | - | 244,800 |
| Payment of cash dividends on common stock | 246,100 | 245,800 | 245,500 | - |
| Capital lease payments | 400 | 400 | 400 | 400 |
| Other financing | 0 | -500 | -2,800 | -2,800 |
| Net cash used in financing activities | -283,000 | -355,800 | -443,900 | 35,800 |
| Net (decrease) increase in cash and cash equivalents | 13,900 | -329,700 | -205,200 | 185,700 |
| Cash and cash equivalents at beginning of period | 236,800 | 566,500 | 771,700 | 586,000 |
| Cash and cash equivalents at end of period | 250,700 | 236,800 | 566,500 | 771,700 |
MICROCHIP TECHNOLOGY INC (MCHPP)
MICROCHIP TECHNOLOGY INC (MCHPP)